Can you provide the last earnings date for COCRYSTAL PHARMA INC?
COCRYSTAL PHARMA INC (COCP) last reported earnings on 3/9/2026.
COCRYSTAL PHARMA INC (COCP) Earnings History & Surprises
NASDAQ:COCP • US19188J4094
Current stock price
1.44 USD
-0.03 (-2.04%)
At close:
1.4108 USD
-0.03 (-2.03%)
After Hours:
COCP Earnings overview
Past quarterly earnings results for COCRYSTAL PHARMA INC (COCP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.14
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 9, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.17
- EPS Surprise
- 4.76%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.17 | -0.18 | 4.76% | 46.88% | - | - | ||
| Q3 2025 | -0.19 | -0.21 | 11.30% | 61.22% | - | - | ||
| Q2 2025 | -0.20 | -0.31 | 34.64% | 62.26% | - | - | ||
| Q1 2025 | -0.23 | -0.52 | 55.35% | 41.03% | - | - | ||
| Q4 2024 | -0.32 | -0.54 | 40.81% | 27.27% | - | - | ||
| Q3 2024 | -0.49 | -0.58 | 15.72% | -19.51% | - | - | ||
| Q2 2024 | -0.53 | -0.49 | -9.01% | -29.27% | - | - | ||
| Q1 2024 | -0.39 | -0.55 | 29.19% | 39.06% | - | - | ||
| Q4 2023 | -0.44 | -0.61 | 27.70% | 20.00% | - | - | ||
| Q3 2023 | -0.41 | -0.54 | 24.16% | 41.43% | - | - | ||
| Q2 2023 | -0.41 | -0.59 | 30.70% | 86.33% | 272.003K | -100.00% | - | |
| Q1 2023 | -0.64 | -0.69 | 7.04% | -33.33% | 255K | -100.00% | - | |
| Q4 2022 | -0.55 | -0.74 | 25.80% | -14.58% | - | - | ||
| Q3 2022 | -0.70 | -0.49 | -42.97% | -45.83% | 84.997K | -100.00% | - | |
| Q2 2022 | -3.00 | -0.53 | -465.65% | -525.00% | 84.997K | -100.00% | - | |
| Q1 2022 | -0.48 | -0.43 | -12.04% | - | 637.5K | -100.00% | - | |
| Q4 2021 | -0.48 | -0.49 | 1.96% | -100.00% | - | -100.00% | ||
| Q3 2021 | -0.48 | -0.49 | 1.96% | 20.00% | 280.5K | -100.00% | -100.00% | |
| Q2 2021 | -0.48 | -0.43 | -12.04% | 42.86% | 280.5K | -100.00% | -100.00% | |
| Q1 2021 | -0.48 | -0.55 | 12.85% | 20.00% | 561K | -100.00% | -100.00% | |
| Q4 2020 | -0.24 | -0.49 | 50.98% | - | 510K | 591.6K | -13.79% | - |
| Q3 2020 | -0.60 | -0.61 | 1.96% | - | 490K | 571.2K | -14.22% | - |
| Q2 2020 | -0.84 | -0.49 | -71.57% | - | 550K | 459K | 19.83% | - |
| Q1 2020 | -0.60 | -0.98 | 38.73% | - | 460K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
35.52%
Max EPS beat (4)
55.35%
Min EPS beat (4)
11.30%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, COCP has consistently beaten EPS estimates in all releases
In the last 4 quarters, COCP has beaten the EPS estimates by 35.5% on average.
Related analysis
COCRYSTAL PHARMA INC / COCP Earnings FAQ
Can you provide information on whether COCRYSTAL PHARMA INC beat earnings estimates in the last quarter?
COCRYSTAL PHARMA INC (COCP) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often COCRYSTAL PHARMA INC beats earnings estimates?
In the last 4 quarters, COCRYSTAL PHARMA INC (COCP) has beaten EPS estimates in 4 out of 4 releases.